# US 2026/0090980 A1 · Cosmetic compositions and methods of using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0090980 A1
- Document ID: US20260090980A1
- Status: Published application
- Kind: A1
- Application number: 19/113,771
- Filed: 2023-09-22
- Published: 2026-04-02
- Earliest claimed: 2022-09-27
- Assignees: Mary Kay Inc.
- Applicants: Mary Kay Inc.
- Inventors: Geetha KALAHASTI
- Web page: https://patentgrep.com/patent/US20260090980A1

## CPC

- A61K 8/9711: Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
- A61K 8/4953: {containing pyrimidine ring derivatives, e.g. minoxidil}
- A61K 8/602: {Glycosides, e.g. rutin}
- A61K 8/922: {of vegetable origin}
- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 8/9794: Liliopsida [monocotyledons]
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention relates generally to methods and compositions useful for treating skin, and in particular to improve the appearance of droopy, loose, sagging, and/or flaccid skin and/or to improve facial contouring. In some aspects, disclosed are methods comprising topically applying to the skin an effective amount of a topical composition comprising escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Argania spinosa oil, Rosmarinus officianalis leaf extract, and/or Morus alba fruit extract.

## Claims

### Claim 1

A method of treating skin, the method comprising topically applying to the skin an effective amount of a topical composition comprising escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Argania spinosa oil, Rosmarinus officianalis leaf extract, and/or Morus alba fruit extract, wherein the skin is treated.

### Claim 2 (depends on 1)

The method of claim 1, wherein the skin is treated to improve the appearance of droopy, loose, sagging, and/or flaccid skin and/or to improve facial contouring, and wherein the appearance of loose, sagging, and/or flaccid skin is improved and/or facial contouring is improved.

### Claim 3 (depends on 1)

The method of claim 1, wherein the skin is treated to increase elasticity, and wherein skin elasticity is increased.

### Claim 4 (depends on 1)

The method of claim 1, wherein the skin is treated to increase the expression of UCP-1 protein, and wherein expression of UCP-1 protein is increased.

### Claim 5 (depends on 1)

The method of claim 1, wherein the skin is treated to increase the expression of dermal matrix proteins, and wherein the expression of dermal matrix proteins is increased.

### Claim 6 (depends on 1)

The method of claim 1, wherein the Coleus barbatus extract is an extract from the root, the Hedychium coronarium root extract is a water and glycerin extract, and/or the Morus alba fruit extract is a water and glycerol extract.

### Claim 7 (depends on 1)

The method of claim 1, wherein the topical composition is an emulsion, serum, gel, gel emulsion, or gel serum.

### Claim 8 (depends on 1)

The method of claim 1, wherein the topical composition is an oil in water emulsion or a water in oil emulsion.

### Claim 9 (depends on 1)

The method of claim 1, wherein the composition is applied to skin in the eye area.

### Claim 10 (depends on 9)

The method of claim 9, wherein the skin of the eyelid is treated to improve the appearance of droopy, loose, sagging, and/or flaccid skin and/or to improve facial contouring, to increase skin elasticity, to increase production of UCP-1 protein, and/or increase dermal matrix protein expression.

### Claim 11

A topical composition comprising escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Rosmarinus officianalis leaf extract, and/or Morus alba fruit extract.

### Claim 12 (depends on 11)

The topical composition of claim 11, wherein the topical composition comprises an effective amount of escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Rosmarinus officianalis leaf extract, and/or Morus alba fruit extract to improve the appearance of droopy, loose, sagging, and/or flaccid skin and/or to improve facial contouring.

### Claim 13 (depends on 11)

The topical composition of claim 11, wherein the topical composition comprises an effective amount of escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Rosmarinus officianalis leaf extract, and/or Morus alba fruit extract to increase skin elasticity.

### Claim 14 (depends on 11)

The topical composition of claim 11, wherein the topical composition comprises an effective amount of escin, Ascophyllum nodosum extract, caffeine, Coleus barbatus extract, Hedychium coronarium root extract, Rosmarinus officianalis leaf extract, and/or Morus alba fruit extract to increase production of UCP-1 protein and/or increase dermal matrix protein expression.

### Claim 15 (depends on 11)

The topical composition of claim 11, wherein the Coleus barbatus extract is an extract from the root, the Hedychium coronarium root extract is a water and glycerin extract, and/or the Morus alba fruit extract is a water and glycerol extract.

### Claim 16 (depends on 11)

The topical composition of claim 11, wherein the topical composition is an emulsion, serum, gel, gel emulsion, or gel serum.

### Claim 17 (depends on 11)

The topical composition of claim 11, wherein the topical composition is an oil in water emulsion or water in oil emulsion.
